Unilever to weigh raising offer for GSK's consumer assets - Bloomberg

1 minute read

The company logo for Unilever is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., February 17, 2017. REUTERS/Brendan McDermid/File Photo

Register now for FREE unlimited access to Reuters.com

Jan 16 (Reuters) - Unilever Plc (ULVR.L) has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc's (GSK.L) consumer products division, Bloomberg reported on Sunday, citing people familiar with the matter.

Unilever and GSK did not immediately respond to Reuters' requests for comment.

The news came a day after GSK said it had rejected a 50-billion-pound ($68.37 billion) offer from Unilever for the consumer goods arm. GSK said it had received three bids from Unilever, the latest on Dec. 20. read more

Unilever could eventually sell some non-core assets from the GSK portfolio to buyers including private equity firms, which could help fund an acquisition, the Bloomberg report added.

($1 = 0.7314 pounds)

Register now for FREE unlimited access to Reuters.com
Reporting by Maria Ponnezhath in Bengaluru; Editing by Andrew Cawthorne

Our Standards: The Thomson Reuters Trust Principles.